Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza
Annals of Internal Medicine, 10/06/09
Khazeni N et al. – This review of 7 trials assessing the efficacy and safety of extended–duration (>4 weeks) treatment with oseltamivir and zanamivir suggests that the drugs prevent symptomatic but not asymptomatic seasonal influenza. Extended–duration zanamivir and oseltamivir chemoprophylaxis seems to be highly efficacious for preventing symptomatic influenza among immunocompetent white and Japanese adults. Extended–duration oseltamivir is associated with increased nausea and vomiting. Safety and efficacy in several subpopulations that might receive extended–duration influenza chemoprophylaxis are unknown.
Related Articles
Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options
Current Drug Targets, 10/23/09
Relevance Score: 89%
The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09
Relevance Score: 88%
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine, 10/05/09
Relevance Score: 80%
Relationship between equipment and infrastructure for pandemic influenza and performance in an avian flu drill
Emergency Medicine Journal, 10/23/09
Relevance Score: 79%
Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic
Annals of Internal Medicine, 10/13/09
Relevance Score: 79%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
ACC, AHA Update Guidelines for Beta Blockers
American Family Physician, 12/17/09
Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/17/09
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?
Journal of General Internal Medicine, 12/17/09
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman
Journal of Medical Microbiology, 12/17/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Grading and Reporting Health and Health Disparities
Preventing Chronic Disease, 12/17/09
Omega-3 fatty acids and cognitive function in women
Women's Health, 12/17/09
Ethnic and Regional Differences in Prevalence and Correlates of Chronic Diseases and Risk Factors in Northern Canada
Preventing Chronic Disease, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


